Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04723537 |
|---|---|
| Brief Title: | Upamostat, a Serine Protease Inhibitor, or Placebo for Treatment of COVID-19 Disease |
| First Submitted : | January 18, 2021 |
| First Submitted that Met QC Criteria : | January 21, 2021 |
| First Posted : | January 25, 2021 |
| Last Update Submitted that Met QC Criteria : | November 15, 2021 |
| Last Update Posted : | November 16, 2021 |